Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines Ursula WiedermannAdam B. DavisChristoph C. Zielinski Review 23 January 2013 Pages: 1 - 12
Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature Adriana J. G. Maaskant-BraatAdri C. VoogdGrard A. P. Nieuwenhuijzen Review 23 January 2013 Pages: 13 - 20
Molecularly targeted therapies for metastatic triple-negative breast cancer Soley BayraktarStefan Glück Review 29 January 2013 Pages: 21 - 35
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes Bárbara MesquitaPaula LopesManuel R. Teixeira Preclinical Study 18 January 2013 Pages: 37 - 45
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer Antoinette HollestelleJustine K. PeetersJohn W. M. Martens Preclinical Study 22 January 2013 Pages: 47 - 57
The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis Xin DuXiao-Qing LiYu-Mei Feng Preclinical study 10 February 2013 Pages: 59 - 67
Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic Kumar Chandra-KuntalJoomin LeeShivendra V. Singh Preclinical study 15 February 2013 Pages: 69 - 79
Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype Peeter KarihtalaPäivi AuvinenYlermi Soini Preclinical study 15 February 2013 Pages: 81 - 90
Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease Janice DiazLesley SteadSusan Fineberg Preclinical Study 17 February 2013 Pages: 91 - 97
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005) Edith A. PerezMichael F. PressDennis J. Slamon Preclinical study Open access 19 February 2013 Pages: 99 - 108
Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells Venkataswarup TiriveedhiTimothy P. FlemingT. Mohanakumar Clinical Trial 08 June 2012 Pages: 109 - 118
Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile Ji Hyun YoukHye Mi GweonJoon Jeong Clinical Trial 17 January 2013 Pages: 119 - 126
Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation Chirag ShahThomas B. LanniFrank Vicini Clinical trial 18 January 2013 Pages: 127 - 135
The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer Shi-Yi WangKaren M. KuntzBeth A. Virnig Clinical Trial 25 January 2013 Pages: 137 - 147
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology Sally Anne GarnettMiguel MartinAngelo Di Leo Clinical trial Open access 03 February 2013 Pages: 149 - 155
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer Ben P. HaynesGiuseppe VialeMitch Dowsett Clinical Trial 03 February 2013 Pages: 157 - 165
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors Ting BaoLing CaiVered Stearns Clinical Trial 08 February 2013 Pages: 167 - 174
A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue Margit M. McGowanBurton L. EisenbergWilliam B. Kinlaw Clinical Trial 16 February 2013 Pages: 175 - 183
Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis P. HadjiV. ZillerK. Kostev Epidemiology 20 January 2013 Pages: 185 - 191
Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose Sarah Q. ToEvan R. SimpsonColin D. Clyne Epidemiology 22 January 2013 Pages: 193 - 203
Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011 Monica S. KrishnanAbram RechtRinaa S. Punglia Epidemiology 22 January 2013 Pages: 205 - 213
Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study Adam J. OlszewskiYazan MigdadyTheresa Shao Epidemiology 26 January 2013 Pages: 215 - 223
Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment Gregory S. CalipDenise M. BoudreauElizabeth T. Loggers Epidemiology 29 January 2013 Pages: 225 - 233
Cadmium exposure and the risk of breast cancer in Japanese women Chisato NagataYasuko NagaoYoshitomo Kashiki Epidemiology 29 January 2013 Pages: 235 - 239
Time-trends in survival in young women with breast cancer in a SEER population-based study Foluso O. AdemuyiwaAdrienne GromanChristine Ambrosone Epidemiology 01 February 2013 Pages: 241 - 248
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study Roberto Pastor-BarriusoNieves AscunceMarina Pollán Epidemiology Open access 03 February 2013 Pages: 249 - 259
Bone mineral density and risk of breast cancer in postmenopausal women Xinhua QuXiaoyu ZhangKerong Dai Epidemiology 05 February 2013 Pages: 261 - 271
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? Steven A. NarodKelly MetcalfeJan Lubinski Epidemiology 06 February 2013 Pages: 273 - 279
Racial differences in outcomes of triple-negative breast cancer Jose M. PachecoFeng GaoCynthia X. Ma Epidemiology 12 February 2013 Pages: 281 - 289
Night-shift work and risk of breast cancer: a systematic review and meta-analysis Biren B. KamdarAna I. TergasJiwon Oh Epidemiology 12 February 2013 Pages: 291 - 301
Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases Edoardo BotteriElisabetta MunzoneAron Goldhirsch Epidemiology 15 February 2013 Pages: 303 - 310
Comparative estimation of percentage breast tissue density for digital mammography, digital breast tomosynthesis, and magnetic resonance imaging Alberto TagliaficoGiulio TagliaficoNehmat Houssami Brief Report 22 January 2013 Pages: 311 - 317
Landscape and evolution of therapeutic research for breast cancer patients Semih DoganMaria Vittoria DieciFabrice Andre Brief Report 14 February 2013 Pages: 319 - 324
A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians Laetitia HuiartCyril FerdynusRoch Giorgi Letter to the Editor 12 February 2013 Pages: 325 - 328
LC3A and its co-relationship with clinical prognosis in systemic tumors Shailendra Kapoor Letter to the Editor 14 February 2013 Pages: 329 - 330
